February 22, 2017 / 9:35 PM / in 9 months

BRIEF-Bluebird bio qtrly net loss per share $1.88

Feb 22 (Reuters) - Bluebird Bio Inc:

* Bluebird Bio reports fourth quarter and full year 2016 financial results and recent operational progress

* Bluebird Bio Inc - collaboration revenue was $1.6 million for Q4 of 2016 compared to $1.5 million

* Bluebird Bio - expects cash, cash equivalents of $884.8 million as of Dec 31, 2016 to be sufficient to fund its current operations into H2 of 2019

* Bluebird Bio Inc qtrly net loss per share - basic and diluted $1.88 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below